Despite the block in apoptosis and greatly reduced total cell death in the absence of BAX, we observed that the overall in vitro sensitivity determined by SRB or MTT assays was no different between BAX+/− and BAX−/− HCT116 human colon cancer cells. The gene discussed is BAX; the disease is colonic neoplasm.